Hydrochloric Acid → 4-(6-(azetidin-3-ylmethyl)-2-(2-isopropyl-1H-benzo[d]imidazol-1-yl)pyrido[3,2-d]pyrimidin-4-yl)morpholine
반응식
[CH:1]([CH3:2])([CH3:3])[c:4]1[n:5][c:6]2[c:7]([n:8]1-[c:9]1[n:10][c:11]([N:31]3[CH2:32][CH2:33][O:34][CH2:35][CH2:36]3)[c:12]3[c:13]([n:14]1)[cH:15][cH:16][c:17]([CH2:19][CH:20]1[CH2:21][N:22]([C:24]([O:25][C:26]([CH3:27])([CH3:28])[CH3:29])=[O:30])[CH2:23]1)[n:18]3)[cH:37][cH:38][cH:39][cH:40]2.[ClH:41].[O:42]1[CH2:43][CH2:44][O:45][CH2:46][CH2:47]1>>[CH:1]([CH3:2])([CH3:3])[c:4]1[n:5][c:6]2[c:7]([n:8]1-[c:9]1[n:10][c:11]([N:31]3[CH2:32][CH2:33][O:34][CH2:35][CH2:36]3)[c:12]3[c:13]([n:14]1)[cH:15][cH:16][c:17]([CH2:19][CH:20]1[CH2:21][NH:22][CH2:23]1)[n:18]3)[cH:37][cH:38][cH:39][cH:40]2참가 물질
4
반응물 3
생성물 1
출처 및 근거
- ORD 기록
- ord-0570743aa95c4e5db66fc877e0b1ab9f
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (3/10)